nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—Brotizolam—PTAFR—polycystic ovary syndrome	0.201	0.958	CrCbGaD
Adinazolam—CYP2C19—urine—polycystic ovary syndrome	0.0363	0.114	CbGeAlD
Adinazolam—CYP3A4—urine—polycystic ovary syndrome	0.0215	0.0674	CbGeAlD
Adinazolam—GABRG3—pituitary gland—polycystic ovary syndrome	0.02	0.0629	CbGeAlD
Adinazolam—GABRB1—pituitary gland—polycystic ovary syndrome	0.0155	0.0486	CbGeAlD
Adinazolam—GABRP—endometrium—polycystic ovary syndrome	0.0153	0.0481	CbGeAlD
Adinazolam—GABRP—uterus—polycystic ovary syndrome	0.0141	0.0444	CbGeAlD
Adinazolam—GABRA4—pituitary gland—polycystic ovary syndrome	0.014	0.0439	CbGeAlD
Adinazolam—GABRP—pituitary gland—polycystic ovary syndrome	0.0139	0.0436	CbGeAlD
Adinazolam—GABRB1—vagina—polycystic ovary syndrome	0.0128	0.0403	CbGeAlD
Adinazolam—GABRE—endometrium—polycystic ovary syndrome	0.0117	0.0367	CbGeAlD
Adinazolam—GABRG2—pituitary gland—polycystic ovary syndrome	0.0117	0.0367	CbGeAlD
Adinazolam—GABRP—vagina—polycystic ovary syndrome	0.0115	0.0361	CbGeAlD
Adinazolam—GABRA3—endocrine gland—polycystic ovary syndrome	0.0111	0.0349	CbGeAlD
Adinazolam—GABRA2—adipose tissue—polycystic ovary syndrome	0.0106	0.0334	CbGeAlD
Adinazolam—GABRE—pituitary gland—polycystic ovary syndrome	0.0106	0.0333	CbGeAlD
Adinazolam—GABRE—adipose tissue—polycystic ovary syndrome	0.0106	0.0331	CbGeAlD
Adinazolam—GABRA2—adrenal gland—polycystic ovary syndrome	0.00955	0.03	CbGeAlD
Adinazolam—GABRE—adrenal gland—polycystic ovary syndrome	0.00947	0.0297	CbGeAlD
Adinazolam—GABRB3—pituitary gland—polycystic ovary syndrome	0.00898	0.0282	CbGeAlD
Adinazolam—GABRA2—vagina—polycystic ovary syndrome	0.00885	0.0278	CbGeAlD
Adinazolam—GABRE—female gonad—polycystic ovary syndrome	0.00883	0.0277	CbGeAlD
Adinazolam—GABRE—vagina—polycystic ovary syndrome	0.00877	0.0275	CbGeAlD
Adinazolam—GABRB3—endocrine gland—polycystic ovary syndrome	0.00696	0.0218	CbGeAlD
Adinazolam—CYP2C19—vagina—polycystic ovary syndrome	0.00644	0.0202	CbGeAlD
Adinazolam—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00603	0.0189	CbGeAlD
Adinazolam—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00528	0.0252	CrCbGaD
Adinazolam—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00356	0.0112	CbGeAlD
Adinazolam—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.00355	0.0169	CrCbGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00136	0.00289	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00135	0.00287	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00134	0.00284	CbGpPWpGaD
Adinazolam—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00134	0.00284	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—DLG4—polycystic ovary syndrome	0.00134	0.00283	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00133	0.00282	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00133	0.00282	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00132	0.0028	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.00132	0.0028	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00132	0.00279	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.0013	0.00277	CbGpPWpGaD
Adinazolam—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00129	0.00273	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00129	0.00273	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00128	0.00272	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00128	0.00271	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00127	0.0027	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00126	0.00268	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00126	0.00266	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00125	0.00265	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00124	0.00264	CbGpPWpGaD
Adinazolam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00124	0.00262	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00123	0.00262	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00123	0.0026	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00123	0.0026	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00121	0.00256	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.0012	0.00255	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00117	0.00249	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00117	0.00249	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00116	0.00247	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00116	0.00246	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00115	0.00245	CbGpPWpGaD
Adinazolam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00115	0.00243	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00115	0.00243	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00114	0.00241	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00113	0.0024	CbGpPWpGaD
Adinazolam—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00113	0.0024	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00113	0.00239	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00111	0.00235	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—DLG4—polycystic ovary syndrome	0.0011	0.00233	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00109	0.00232	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—DLG4—polycystic ovary syndrome	0.00108	0.0023	CbGpPWpGaD
Adinazolam—CYP2C19—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00107	0.00227	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00105	0.00223	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00105	0.00222	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—DLG4—polycystic ovary syndrome	0.00103	0.00218	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00102	0.00216	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—DLG4—polycystic ovary syndrome	0.00101	0.00215	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00101	0.00214	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.001	0.00212	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000982	0.00208	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000976	0.00207	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000967	0.00205	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000958	0.00203	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000937	0.00199	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00093	0.00197	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—DLG4—polycystic ovary syndrome	0.000927	0.00196	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000925	0.00196	CbGpPWpGaD
Adinazolam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000924	0.00196	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000923	0.00196	CbGpPWpGaD
Adinazolam—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000912	0.00193	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—DLG4—polycystic ovary syndrome	0.0009	0.00191	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.000884	0.00187	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000878	0.00186	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000871	0.00185	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000869	0.00184	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—DLG4—polycystic ovary syndrome	0.000863	0.00183	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00086	0.00182	CbGpPWpGaD
Adinazolam—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000853	0.00181	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—DLG4—polycystic ovary syndrome	0.000847	0.0018	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000838	0.00178	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00083	0.00176	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000818	0.00173	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000812	0.00172	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000805	0.00171	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000792	0.00168	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000772	0.00164	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00076	0.00161	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000758	0.00161	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000749	0.00159	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000747	0.00158	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000741	0.00157	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000736	0.00156	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000719	0.00152	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000706	0.0015	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000706	0.0015	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00069	0.00146	CbGpPWpGaD
Adinazolam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000689	0.00146	CbGpPWpGaD
Adinazolam—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000688	0.00146	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000681	0.00144	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000674	0.00143	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000671	0.00142	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000662	0.0014	CbGpPWpGaD
Adinazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000662	0.0014	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000652	0.00138	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000643	0.00136	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000625	0.00133	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000624	0.00132	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000615	0.0013	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000608	0.00129	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000606	0.00129	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.0006	0.00127	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000597	0.00127	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000592	0.00126	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000568	0.00121	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000568	0.00121	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000565	0.0012	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000565	0.0012	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000559	0.00119	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000559	0.00118	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000558	0.00118	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000556	0.00118	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000555	0.00118	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000549	0.00116	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000549	0.00116	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000546	0.00116	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000533	0.00113	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000524	0.00111	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000517	0.0011	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000515	0.00109	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000511	0.00108	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00051	0.00108	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00051	0.00108	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000502	0.00106	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000496	0.00105	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000494	0.00105	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000488	0.00104	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000487	0.00103	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000487	0.00103	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000479	0.00101	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000476	0.00101	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000475	0.00101	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000467	0.00099	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000467	0.00099	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000465	0.000987	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000458	0.000972	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000456	0.000966	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000454	0.000962	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000452	0.000957	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000451	0.000955	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000449	0.000953	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000445	0.000944	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000439	0.000931	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000438	0.000928	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000435	0.000922	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000434	0.00092	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000431	0.000913	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000428	0.000908	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000427	0.000905	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000414	0.000879	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000408	0.000865	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000404	0.000856	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000398	0.000844	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000398	0.000844	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000393	0.000832	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000392	0.000832	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000392	0.000831	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000381	0.000807	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000376	0.000797	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000375	0.000796	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000374	0.000792	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000373	0.000791	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00037	0.000785	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000367	0.000779	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000366	0.000777	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000365	0.000774	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000358	0.00076	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.00035	0.000742	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000336	0.000712	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000334	0.000708	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000326	0.000692	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.00032	0.000679	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.00032	0.000679	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000316	0.00067	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000313	0.000664	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000298	0.000631	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000297	0.00063	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000297	0.000629	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000293	0.000621	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000291	0.000617	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000272	0.000576	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000271	0.000575	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000258	0.000547	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000253	0.000537	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000253	0.000537	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000243	0.000516	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00024	0.000508	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000239	0.000508	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000236	0.000501	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000212	0.00045	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000211	0.000446	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000201	0.000426	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000193	0.000408	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000193	0.000408	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000192	0.000407	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00019	0.000402	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000179	0.00038	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000178	0.000378	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000171	0.000363	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000163	0.000346	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000161	0.000342	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000153	0.000324	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000152	0.000323	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000152	0.000323	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000149	0.000315	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000145	0.000308	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000141	0.000299	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.00013	0.000275	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000128	0.00027	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000126	0.000266	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000121	0.000257	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000121	0.000256	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000116	0.000246	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000116	0.000245	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000115	0.000245	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000115	0.000243	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000114	0.000242	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.000108	0.00023	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.000107	0.000226	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000103	0.000218	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.81e-05	0.000208	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TH—polycystic ovary syndrome	9.23e-05	0.000196	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	8.98e-05	0.00019	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.95e-05	0.00019	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.74e-05	0.000185	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.47e-05	0.00018	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	8.45e-05	0.000179	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.79e-05	0.000165	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.55e-05	0.00016	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	7.54e-05	0.00016	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.28e-05	0.000154	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	7.18e-05	0.000152	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.99e-05	0.000148	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.9e-05	0.000146	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	6.81e-05	0.000144	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.52e-05	0.000138	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.42e-05	0.000136	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	6.35e-05	0.000135	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.55e-05	0.000118	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.4e-05	0.000115	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	5.15e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.08e-05	0.000108	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	5.08e-05	0.000108	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—INS—polycystic ovary syndrome	5.05e-05	0.000107	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.53e-05	9.61e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.32e-05	9.16e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.09e-05	8.68e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.82e-05	8.09e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.09e-05	6.56e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.05e-05	6.47e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.04e-05	6.44e-05	CbGpPWpGaD
